Blocking TNFα attenuates progressive cartilage matrix degradation in inflammatory arthritis

xlomafota13 shared this article with you from Inoreader Blocking TNFα attenuates progressive cartilage matrix degradation in inflammatory arthritis Via Experimental and therapeutic medicine Exp Ther Med. 2021 Aug;22(2):808. doi: 10.3892/etm.2021.10240. Epub 2021 May 27. ABSTRACT Because damage to hyaline cartilage is irreversible, relieving progressive cartilage destruction is an important therapeutic approach for inflammatory arthritis. In the present study, human hyaline chondrocytes were isolated from total knee replacements of 15 patients with osteoarthritis (OA) and three with rheumatoid arthritis (RA). Synovial fluid of OA (n=25) and RA (n=34) were collected to measure tumor necrosis factor α (TNFα) using ELISA. Consistent with previous studies, the synovial fluid exhibited high TNFα levels and hyaline cartilage was severely destroyed in patients with RA. TNFα-treated chondrocytes were used as model for inflammatory arthritis. TNFα did not influence proliferation or extracellular matrix expression in chondrocytes, but induced matrix metalloproteinase (MMP)1, 3 and 13 expression levels in chondrocytes, which was accompanied by activation of nuclear factor-κB signaling. During chondrogenic differentiation, TNFα attenuated mRNA expression levels of anabolic factors (collagen type 2 and aggrecan) and enhanced mRNA expression of catabolic factors (MMP1, MMP3 and MMP13) in chondrocytes. Moreover, anti-TNFα agents (Golimumab) inhibited the TNFα-induced metabolic shift in chondrocytes and chondrogenic differentiation. The present study revealed a mechanism by which TNFα may induce metabolic shift in chondrocytes, leading to progressive chondrocyte destruction. PMID:34093764 | PMC:PMC8170641 | DOI:10.3892/etm.2021.10240 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.